MRI and PET of bone marrow in lymphoproliferative diseases

MRI and PET of bone marrow in lymphoproliferative diseases

In lymphoproliferative diseases, bone marrow involvement (BMI) is an essential parameter influencing staging, prognosis and treatment. In addition to pathological analysis of blind bone marrow biopsy, MRI and PET can help to (a) estimate initial BMI and assess the stage of disease, (b) indicate prog...

Full description

Bibliographic Details
Main Authors:	Rahmouni, A., Meignan, M., Divine, M., Luciani, A., Haioun, C., Montazel, J.-L., Kobeiter, H.
Format:	Online
Language:	English
Published:	BioMed Central 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448641/

Similar Items

Whole body MRI and PET/CT in haematological malignancies
by: Lin, Chieh, et al.
Published: (2007)

Lymphoma: imaging in the evaluation of residual masses
by: Rahmouni, A., et al.
Published: (2015)

Whole-body diffusion magnetic resonance imaging in the assessment of lymphoma
by: Lin, Chieh, et al.
Published: (2012)

MRI and PET in monitoring response in lymphoma: Wednesday 5 October 2005, 08:30–10:00
by: Rahmouni, Alain, et al.
Published: (2005)

FDG-PET in lymphoma
by: Meignan, Michel
Published: (2014)

MRI features of intrahepatic extramedullary haematopoiesis in sickle cell anaemia
by: Jelali, Mohamed Ali, et al.
Published: (2006)

Malignant Lymphoproliferative Diseases
by: Garrett, J. V.
Published: (1981)

Correlations of hematological parameters with bone marrow findings in chronic lymphoproliferative disorders associated with hepatitis viruses
by: Ciufu, C, et al.
Published: (2013)

Whole-body DWI in patients with lymphoma: imaging findings, pitfalls, and limitations
by: Rahmouni, Alain, et al.
Published: (2014)

Posttransplant Lymphoproliferative Disorders
by: Ibrahim, Hazem A. H., et al.
Published: (2012)

Neutropenia and G-CSF in lymphoproliferative diseases
by: Ria, Roberto, et al.
Published: (2013)

Spatial mapping of functional pelvic bone marrow using FLT PET
by: McGuire, Sarah M., et al.
Published: (2014)

The Bone Marrow in Malignant Disease
by: Pillers, E. M. Kingsley, et al.
Published: (1956)

Transgenic mouse model of IgM+ lymphoproliferative disease mimicking Waldenström macroglobulinemia
by: Tompkins, V S, et al.
Published: (2016)

Fluorodeoxyglucose PET-CT Findings Following Bone Marrow Harvesting
by: Matthews, Robert, et al.
Published: (2012)

The Value of PET/CT in Detecting Bone Marrow Involvement in Patients With Follicular Lymphoma
by: Perry, Chava, et al.
Published: (2016)

The Clinical Utility of FDG PET-CT in Evaluation of Bone Marrow Involvement by Lymphoma
by: Kim, Ho Young, et al.
Published: (2015)

Immuno-histological diagnosis of lymphoproliferative diseases by selected combinations of antisera and monoclonal antibodies.
by: Janossy, G., et al.
Published: (1980)

Posttransplant Lymphoproliferative Disease after Lung Transplantation
by: Neuringer, Isabel P.
Published: (2013)

EBV-Positive T/NK-Cell Lymphoproliferative Disease of Childhood
by: Hong, Mineui, et al.
Published: (2013)

Heart rate variability in patients with lymphoproliferative diseases in remission
by: B. B. Samura
Published: (2018-08-01)

The Therapeutic Strategy of HDAC6 Inhibitors in Lymphoproliferative Disease
by: Maria Cosenza, et al.
Published: (2018-08-01)

Bone Marrow Abnormalities in HIV Disease
by: Dhurve, Sharad A., et al.
Published: (2013)

JAK-STAT in lymphoproliferative disorders
by: Rabadan, Raul, et al.
Published: (2015)

Intractable diseases treated with intra-bone marrow-bone marrow transplantation
by: Li, Ming, et al.
Published: (2014)

Trisomy 12 is seen within a specific subtype of B-cell chronic lymphoproliferative disease affecting the peripheral blood/bone marrow and co-segregates with elevated expression of CD11a
by: Su'ut, L., et al.
Published: (1998)

T and B cell populations in blood and lymph node in lymphoproliferative disease.
by: Cooper, D. A., et al.
Published: (1975)

An automatic delineation method for bone marrow absorbed dose estimation in 89Zr PET/CT studies
by: Makris, N.E., et al.
Published: (2016)

β-HHVs and HHV-8 in Lymphoproliferative Disorders
by: Quadrelli, C., et al.
Published: (2011)

Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage
by: Crane, Genevieve M., et al.
Published: (2015)

MRI of Residual Red Bone Marrow in the Distal Femur of Healthy Subjects
by: Arslan, Gozde, et al.
Published: (2015)

Generative FDG-PET and MRI Model of Aging and Disease Progression in Alzheimer's Disease
by: Dukart, Juergen, et al.
Published: (2013)

Magnetic resonance imaging of the bone marrow after bone marrow transplantation or immunosuppressive therapy in aplastic anemia.
by: Park, J. M., et al.
Published: (2001)

The usefulness of 18F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD)
by: Watanabe, Shiro, et al.
Published: (2016)

Posttransplant Lymphoproliferative Disorder of the Thorax: CT and FDG-PET Features in a Single Tertiary Referral Center
by: Yoon, Ga Young, et al.
Published: (2015)

Chromosomal aberrations and bone marrow toxicity.
by: Heddle, J A, et al.
Published: (1981)

PET/MRI in infectious and inflammatory diseases: will it be a useful improvement?
by: Glaudemans, Andor W. J. M., et al.
Published: (2012)

Comparison of Non-myeloablative Conditioning Regimens for Lymphoproliferative Disorders
by: Hong, Sanghee, et al.
Published: (2014)

Challenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders
by: Phillips, Tycel, et al.
Published: (2016)

Quantitative CT analysis for assessing response in lymphoma (Cheson’s criteria): Wednesday 5 October 2005, 08:30–10:00
by: Rahmouni, Alain, et al.
Published: (2005)